PRESS RELEASES

Biotalys Submits First Protein-Based Biocontrol Registration Package to the EPA

GHENT, Belgium and RESEARCH TRIANGLE PARK, N.C., Jan. 21, 2021 (GLOBE NEWSWIRE) — Today, Biotalys NV, a transformative food and crop protection company, announces that it has submitted its first protein-based biocontrol, Evoca™, to the Environmental Protection Agency (EPA) in the United States for approval. Pending EPA registration, this biocontrol will offer U.S. fruit and vegetable growers a new way to combat major diseases to maximize yields and extend the shelf life after harvest of produce with substantially lower residues.

“Biotalys is thrilled to have begun the EPA registration process for its first product. While Evoca targets diseases like Botrytis cinerea and powdery mildew, we are leveraging the flexibility of our technology platform to advance a broad pipeline of products with new modes of action that will safely and reliably address key crop pests and diseases across the food value chain,” commented Luc Maertens, COO of Biotalys.

Evoca will help growers effectively control key pathogens in the field, as well as in the food value chain to protect fruits and vegetables post harvest, extending shelf life and reducing decay and food loss. With its new mode of action and favourable safety profile, Evoca provides growers with additional rotational options to manage resistance in a more sustainable way.

The submission follows Biotalys’ successful completion of an extensive field product development program and regulatory studies on Evoca. More than 200 field and greenhouse trials globally demonstrated high consistency in effective control of key pathogens in fruit and vegetables crops. With this submission and pending regulatory approvals, Biotalys is on track to introduce Evoca to select regions in the U.S. market in late 2022.

Biotalys will proceed with international registrations on its own, maintaining full ownership of all rights. Aligned with the go-to-market strategy for Evoca, the submission in the United States will be followed by a submission in the European Union. Major agricultural markets in Latin America and Asia are in scope for future registrations.

Evoca™: Pending Registration. This product is not currently registered for sale or use in the United States and is not being offered for sale.

About Biotalys

Biotalys is a rapidly growing and transformative food and crop protection company developing a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Based on its groundbreaking technology platform, Biotalys has developed a broad pipeline of effective and safe candidate products that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Combining the high-performance characteristics and consistency of chemicals with the clean safety profile of biologicals, Biotalys goal is to provide ideal crop protection agents for both pre- and post-harvest applications. Based in the biotech cluster in Ghent, Belgium, Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and has raised €61 million ($66m USD) to date from specialist international investors. More information can be found on www.biotalys.com.

PDF available: http://ml.globenewswire.com/Resource/Download/c62d03a4-c6f2-4b53-a8d2-8883fcbfd403

Media Contacts:

Erica Camilo
Connexa Communications for Biotalys
T: +1 (610) 639 5644
E: [email protected]com

Latest News

‫ศาลอุทธรณ์มอบชัยชนะครั้งสำคัญให้กับ TriMax เหนือ Wickfire

ศาลอุทธรณ์ภาคห้าออกคำตัดสินชี้ขาดว่า TriMax Media ไม่ได้กระทำการละเมิดกฎหมายใดๆ ต่อ Wickfire L.L.C. ในขณะที่เห็นพ้องต่อคำตัดสินของคณะลูกขุนที่ว่า Wickfire แทรกแซงธุรกิจของ TriMax โดยเจตนา ดัลลัส, March 08, 2021 (GLOBE NEWSWIRE) — หลังจากที่มีการฟ้องร้องมาเจ็ดปี TriMax ได้รับชัยชนะเหนือ Wickfire เมื่อวันที่ 26 กุมภาพันธ์ 2021 ศาลอุทธรณ์ได้ออกคำตัดสินขั้นสุดท้ายว่า Wickfire ไม่มีหลักฐานใดๆ ที่จะสนับสนุนข้อเรียกร้องต่อ TriMaxคำตัดสินดังกล่าวเกิดขึ้นในศาลอุทธรณ์ภาคห้าของสหรัฐอเมริกา หมายเลขคดี 17-3043040คำตัดสินของศาลอุทธรณ์ได้กลับคำตัดสินค่าความเสียหายที่เป็นตัวเงินทั้งหมดที่มอบให้กับ Wickfire ก่อนหน้านี้ คดีความนี้แต่เดิมพิจารณาโดยเขตตะวันตกของรัฐเท็กซัส หมายเลขคดี14-CV-34 ในประเด็นเกี่ยวกับ Google AdWords Auction ซึ่งเป็นแพลตฟอร์มการประมูลออนไลน์ที่บริษัทต่างๆ เช่น TriMax และ Wickfire ได้แข่งขันกันเพื่อพื้นที่โฆษณาWickfire ยืนกรานเรียกร้องต่อ TriMax หลายข้อ แต่ท้ายที่สุด Wickfire ก็ล้มเหลวในทุกข้อ: Wickfire […]

Synchronoss Announces Appointment of Jeff Miller as Permanent CEO and President

BRIDGEWATER, N.J., March 08, 2021 (GLOBE NEWSWIRE) —  Synchronoss Technologies, Inc. (NASDAQ: SNCR), a global leader and innovator of cloud, messaging and digital solutions, today announced that its Board of Directors has confirmed Jeff Miller as its President and Chief Executive Officer. Miller had been serving as interim President and CEO of Synchronoss since September 2020 and joined […]

iRemedy Procures Supply of 500 Million More Low-Dead Space Syringes and Needles in Support of “Project Vaccinate”

STUART, Fla., March 08, 2021 (GLOBE NEWSWIRE) — The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy™ medical supply marketplace, today announced that the Company has arranged for the procurement of an additional 500 million low-dead space syringes and needles in association with iRemedy’s “Project Vaccinate” initiative, created to support global […]

Famed Attorney CHARLES HARDER Releases Book GAWKER SLAYER on Fifth Anniversary of $140 Million Trial Victory For Hulk Hogan Against Gawker Media

GAWKER SLAYER Dubbed “the highest-profile media lawyer in America” by The Hollywood Reporter, and “Hollywood’s favorite lawyer,” by Financial Times, CHARLES HARDER gives readers an inside look at his most famous celebrity cases during his 25-year career. NEW YORK, March 08, 2021 (GLOBE NEWSWIRE) — Coinciding with the fifth anniversary of the landmark $140 million jury […]